Patent · US Active

Heteroaryl compounds and their uses

US8415381B2 · kind B2 · utility

4Cited by

0References

12Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Paul A. Barsanti · Emeryville, US
Cheng Hu · Menlo Park, US
Jeff Jin · Fremont, US
Robert Keyes · Pleasant Prairie, US
Robert Kucejko · Sacramento, US
Xiaodong Lin · Walnut Creek, US
Yue Pan · Albany, US
Keith B. Pfister · Emeryville, US
Martin Sendzik · Belmont, US
James Sutton · Princeton Junction, US
Lifeng Wan · Richmond, US

Key dates

Filing date	Jul 26, 2010
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Nov 5, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D241/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I):and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a disease or condition mediated by CDK9.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.